We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04847466
Brief Title: Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer

First Submitted : April 15, 2021
First Submitted that Met QC Criteria : April 15, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : February 11, 2023
Last Update Posted : February 14, 2023